This is an aggregated industry headline. Read the full story at Drug Channels →
Pharmacy Copay Misuse: The Multi-Billion Dollar Issue Hiding In Plain Sight
Today's guest post comes from Stephen Hom, Co-Founder, EVP & Chief Operating Officer of RIS Rx. Drawing on RIS Rx's proprietary data and case studies, Stephen highlights patterns that can undermine patient support program effectiveness. He argues that a more data-driven approach can help manufacture
By Drug Channels
· Jun 5, 2026
· via Drug Channels
Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its…
The WeekFierceBiotech ↗
On Thursday, the public had the first chance to air their grievances about the FDA's controversial Commissione…
The WeekBriefing
The Trump administration plans to strip job protections from around 8,000 NIH officials overseeing research gr…